Published in Calif Med on March 01, 1971
STUDIES OF CALCIUM AND PHOSPHORUS METABOLISM: IV. The Effect of the Parathyroid Hormone. J Clin Invest (1929) 27.79
Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem (1962) 12.79
Some problems of hyperparathyroidism. Br Med J (1962) 3.90
Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone. J Clin Invest (1969) 3.41
Evidence for a phosphorus-depletion syndrome in man. N Engl J Med (1968) 3.34
Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium. Endocrinology (1962) 3.05
STUDIES IN PARATHYROID PHYSIOLOGY: III. The Effect of Phosphate Ingestion in Clinical Hyperparathyroidism. J Clin Invest (1932) 2.97
BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. J Clin Invest (1965) 2.55
Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med (1966) 2.46
"Activation" of vitamin D by the liver. J Clin Invest (1969) 2.42
Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet (1969) 2.33
The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. J Biol Chem (1968) 2.29
THYROID HYPOCALCEMIC PRINCIPLE AND RECURRENT LARYNGEAL NERVE INJURY AS FACTORS AFFECTING THE RESPONSE TO PARATHYROIDECTOMY IN RATS. Endocrinology (1963) 2.17
Metabolism of vitamin D. A new cholecalciferol metabolite, involving loss of hydrogen at C-1, in chick intestinal nuclei. Biochem J (1969) 1.85
Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology (1969) 1.84
Calcium and phosphorus homeostasis in the parathyroidectomized dog; evaluation by means of ethylenediamine tetraacetate and calcium tolerance tests. J Clin Invest (1960) 1.79
CALCITONIN PRODUCTION AND THE MITOCHONDRION-RICH CELLS OF THE DOG THYROID. Nature (1964) 1.78
Morphology of the osteon. An electron microscopic study. J Bone Joint Surg Am (1966) 1.72
Vitamin D-dependent calcium-binding protein. Response to some physiological and nutritional variables. J Biol Chem (1968) 1.69
The effects of parathyroid extract on renal function in man. J Clin Invest (1957) 1.68
Experimental human magnesium depletion. Medicine (Baltimore) (1969) 1.62
Thyrocalcitonin. Physiol Rev (1969) 1.58
THYROCALCITONIN: HYPOCALCEMIC HYPOPHOSPHATEMIC PRINCIPLE OF THE THYROID GLAND. Science (1964) 1.56
The effects of ACTH and cortisone on the renal tubular transport of uric acid, phosphorus, and electrolytes in patients with normal renal and adrenal function. J Lab Clin Med (1951) 1.49
FURTHER EVIDENCE FOR CALCITONIN. A RAPID-ACTING HORMONE WHICH LOWERS PLASMA-CALCIUM. Lancet (1963) 1.48
Formation, mineralization, and resorption of bone in vitamin D-deficient rats. J Clin Invest (1970) 1.48
Circulating parathyroid hormone concentration in chronic renal insufficiency. Arch Intern Med (1969) 1.39
The hypercalcemia of adrenal insufficiency. J Clin Invest (1963) 1.35
25-Hydroxycholecalciferol: stimulation of bone resorption in tissue culture. Science (1969) 1.31
Thymic and parathyroid origin of calcitonin in man. Lancet (1968) 1.31
Immunofluorescent localization of calcitonin in the 'C' cells of pig and dog thyroid. J Endocrinol (1967) 1.29
Effect of dibutyryl cyclic adenosine 3',5'-monophosphate, theophylline, and other nucleotides upon calcium and phosphate metabolism. J Clin Invest (1968) 1.28
Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness. J Clin Endocrinol Metab (1969) 1.28
Hypocalcemic hypercalciuria during vitamin D and dihydrotachysterol therapy of hypoparathyroidism. J Clin Endocrinol Metab (1958) 1.28
The influence of extracellular volume expansion on renal phosphate reabsorption in the dog. J Clin Invest (1969) 1.26
The physicochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med (1969) 1.26
EFFECTS OF SERUM CALCIUM LEVEL AND PARATHYROID EXTRACTS ON PHOSPHATE AND CALCIUM EXCRETION IN HYPOPARATHYROID PATIENTS. J Clin Invest (1965) 1.25
Cytochemical evidence for an ultimobranchial origin of rodent thyroid C cells. Nature (1967) 1.22
The effect of parathyroid extract on renal tubular calcium reabsorption in the dog. J Clin Invest (1962) 1.22
Effects of purified parathyroid hormone on the calcium metabolism of monkey kidney cells. Endocrinology (1968) 1.21
Effect of thyrocalcitonin on bone. Lancet (1966) 1.21
Inhibition by steroids of parathyroid hormone-induced Ca45 release from embryonic rat bone in vitro. J Pharmacol Exp Ther (1969) 1.19
Effect of expansion of extracellular fluid volume on renal phosphate handling. J Clin Invest (1969) 1.17
Inorganic phosphate treatment of hypercalcemia. Arch Intern Med (1968) 1.15
The influence of plasma magnesium concentration on parathyroid hormone secretion. J Endocrinol (1968) 1.15
Radioimmunoassays of peptide hormones in plasma. N Engl J Med (1967) 1.13
Experimental model for hyperparathyroidism: effect of excessive numbers of transplanted isologous parathyroid glands. J Urol (1966) 1.13
A simplified perfusion method for study of calcium equilibrium in isolated bone. J Physiol (1968) 1.12
Evidence for the biologically active form of cholecalciferol in the intestine. J Biol Chem (1970) 1.11
Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms. J Clin Invest (1970) 1.10
Recent advances in the metabolism and function of vitamin D. Fed Proc (1969) 1.09
Evidence for suppression of parathyroid gland activity by hypermagnesemia. J Clin Invest (1970) 1.07
Decreased thyrocalcitonin in thyroid glands from patients with hyperparathyroidism. J Clin Endocrinol Metab (1967) 1.06
Effects of phosphate loading and depletion on the renal excretion and reabsorption of inorganic phosphate. J Clin Invest (1957) 1.05
Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation. Arch Intern Med (1969) 1.04
Parathyroid hormone secretion in vitro: regulation by calcium and magnesium ions. Nature (1970) 1.03
Studies on the renal clearance of diffusible calcium and the role of the parathyroid glands in its regulation. Yale J Biol Med (1961) 1.03
The influence of the parathyroid glands on the hypercalcemia of experimental magnesium depletion in the rat. J Clin Invest (1968) 1.03
Effect of ions upon bone cell function. Fed Proc (1970) 1.02
Progressive changes in renal phosphate and calcium excretion in rats following parathyroidectomy or parathyroid administration. Proc Soc Exp Biol Med (1954) 1.01
Parathyroid hormone and vitamin D. Yale J Biol Med (1966) 1.01
Physiologic and pharmacologic regulation of bone resorption. N Engl J Med (1970) 1.01
Effects of hypercalcemia and hypocalcemia on the thyrocalcitonin content of rat thyroid glands. Endocrinology (1968) 1.01
Plasma-calcitonin in man. Lancet (1969) 1.00
Parathyroid hormone metabolism in man: effect of nephrectomy. Clin Sci (1969) 1.00
Role of serum Ca, parathyroid hormone, and NaCl infusion on renal Ca and Na clearances. Am J Physiol (1968) 0.98
Renal handling of magnesium in the dog. Am J Physiol (1969) 0.98
25-hydroxycholecalciferol: direct effect on calcium transport. Science (1969) 0.97
The clinical problem of primary hyperparathyroidism. Med Clin North Am (1970) 0.93
Effects of varying phosphate intake in primary hyperparathyroidism. J Clin Endocrinol Metab (1968) 0.93
Control of secretion of thyrocalcitonin in the rabbit as evaluated by radioimmunoassay. Endocrinology (1969) 0.92
A radioimmunoassay for thyrocalcitonin. Proc Natl Acad Sci U S A (1968) 0.90
Effect of parathyroid hormone extract on divalent ion excretion in man. J Clin Endocrinol Metab (1968) 0.89
PSEUDOHYPOPARATHYROIDISM WITH OSTEITIS FIBROSA CYSTICA AND IMPAIRED ABSORPTION OF CALCIUM. J Clin Endocrinol Metab (1963) 0.89
Secondary hyperparathyroidism in chronic renal disease. Arch Intern Med (1969) 0.88
Radioimmunoassay of parathyroid hormone in primary hyperparathyroidism: studies after removal of parathyroid adenoma. Br Med J (1969) 0.88
Cyclic 3',5'-adenylic acid in bone and the mechanism of action of parathyroid hormone. Fed Proc (1970) 0.87
Study of parathyroid function in man by EDTA infusion. J Clin Endocrinol Metab (1969) 0.87
Endocrine regulation of calcium metabolism. Annu Rev Physiol (1970) 0.86
Assay of calcitonin in human plasma. Lancet (1968) 0.85
EFFECT OF GROWTH HORMONE ON TUBULAR TRANSPORT OF PHOSPHATE IN NORMAL AND PARATHYROIDECTOMIZED DOGS. J Clin Invest (1964) 0.84
Parathyroid hormone. Am J Med (1967) 0.84
Effects of thyrocalcitonin on calcium transport in kidney cells. Endocrinology (1969) 0.83
Relationship between vitamin D deficiency, thyrocalcitonin, and parathyroid hormone. Am J Physiol (1967) 0.82
[Thyrocalcitonin. 3. The synthesis of alpha-thyrocalcitonin]. Helv Chim Acta (1968) 0.82
The parathyroidal function in long term dietary experiments. Acta Endocrinol (Copenh) (1954) 0.81
2-Thiophenecarboxylic acid: a hypoglycemic, antilipolytic agent with hypocalcemic and hypophosphatemic effects in rats. Endocrinology (1969) 0.81
Effect of ions upon bone cell function. Discussion. Fed Proc (1970) 0.80
Evidence for the secretion of thyrocalcitonin at normal and subnormal plasma calcium levels. Endocrinology (1968) 0.79
Relation between parathyroid cell mass and plasma calcium concentration in normal and uremic subjects. A theoretical model with an analysis of the concept of autonomy, and speculations on the mechanism of parathyroid hyperplasia. Arch Intern Med (1969) 0.78
Plasma phosphate and the hypocalcemic response of intact, parathyroidectomized and nephrectomized rats to thyrocalcitonin. Endocrinology (1969) 0.78
Magnesium ion and parathyroid function. N Engl J Med (1970) 0.78
Changes in plasma calcium after injection of calcium in hypothyroid and hypoparathyroid women. J Clin Endocrinol Metab (1967) 0.78
A study of the effect of parathyroid hormone on bone remodeling and on calcium homeostasis. Clin Orthop Relat Res (1968) 0.78
Recent advances in thyrocalcitonin research. Fed Proc (1970) 0.76
Cyclic 3',5'-adenylic acid in bone and the mechanism of action of parathyroid hormone. Discussion. Fed Proc (1970) 0.76
Thyrocalcitonin. Annu Rev Pharmacol (1968) 0.76
Enzymatic and other biochemical events accompanying bone resorption in tissue culture. Calcif Tissue Res (1970) 0.76
Studies on the renal clearance of phosphate and the role of the parathyroid glands in its regulation. J Clin Endocrinol Metab (1962) 0.76
Dibutyryl cyclic AMP, vitamin D and intestinal permeability to calcium. Endocrinology (1970) 0.75
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med (1976) 3.47
Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) (1976) 3.11
Diuretic-induced hyponatremia. Ann Intern Med (1971) 2.99
Renal artery embolism: clinical features and long-term follow-up of 17 cases. Ann Intern Med (1978) 2.72
Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med (1989) 2.40
Acute interstitial nephritis due to methicillin. Am J Med (1978) 2.11
Inhibition of antidiuretic hormone secretion by diphenylhydantoin. Arch Neurol (1970) 2.05
Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med (1981) 2.00
Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int (1973) 1.88
Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med (1995) 1.80
A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int (1982) 1.78
Effect of NaCl infusion on urinary Ca++ and Mg++ during reduction in their filtered loads. Am J Physiol (1967) 1.72
Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions. N Engl J Med (1985) 1.68
Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.66
Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. N Engl J Med (1969) 1.64
Stability of the potassium content of cerebrospinal fluid and brain. Am J Physiol (1967) 1.52
Treatment of renal anemia with recombinant human erythropoietin. Am J Nephrol (1989) 1.50
Effect of parathyroid hormone on rat heart cells. J Clin Invest (1981) 1.50
Parathyroid hormone-activated calcium channels in an osteoblast-like clonal osteosarcoma cell line. cAMP-dependent and cAMP-independent calcium channels. J Biol Chem (1987) 1.50
Studies on mechanisms of cerebral edema in diabetic comas. Effects of hyperglycemia and rapid lowering of plasma glucose in normal rabbits. J Clin Invest (1973) 1.47
Antidiuretic principle in tuberculous lung tissue of a patient with pulmonary tuberculosis and hyponatremia. Ann Intern Med (1970) 1.46
Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients. Am J Hypertens (1992) 1.45
Study of intestinal absorption of calcium in patients with renal failure. Kidney Int (1973) 1.45
Amlodipine prevents and reverses the elevation in [Ca2+]i and the impaired phagocytosis of PMNL of diabetic rats. Nephrol Dial Transplant (1997) 1.44
Maintenance peritoneal dialysis as an alternative in the patient with diabetes mellitus and end-stage uremia. Kidney Int Suppl (1974) 1.43
Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis (1991) 1.43
The renal regulation of sodium and potassium in patients with chronic renal failure (CRF) and the effect of diuretics on the excretion of these ions. Ann N Y Acad Sci (1966) 1.40
changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms. J Clin Invest (1972) 1.39
Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man. N Engl J Med (1972) 1.39
On the mechanism of hypophosphatemia during acute hyperventilation: evidence for increased muscle glycolysis. Miner Electrolyte Metab (1983) 1.39
Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med (1982) 1.37
Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance in iliac bone. Calcif Tissue Int (1982) 1.36
Vascular calcification and peripheral necrosis in a renal transplant recipient. Reversal of lesions following subtotal parathyroidectomy. Am J Med (1970) 1.33
Granulomatous sarcoid nephritis. Am J Med (1967) 1.31
The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med (1982) 1.30
A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney Int (2000) 1.29
Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care (2000) 1.28
The quantitative estimation of perfusible glomeruli and the collagen and non-collagen nitrogen of the normal kidney. Nephron (1967) 1.28
Candida peritonitis. Report of 22 cases and review of the English literature. Am J Med (1976) 1.27
Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab (1982) 1.26
The influence of extracellular volume expansion on renal phosphate reabsorption in the dog. J Clin Invest (1969) 1.26
The physicochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med (1969) 1.26
1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure. Ann Intern Med (1974) 1.25
Advances in vitamin D metabolism as they pertain to chronic renal disease. Am J Clin Nutr (1976) 1.25
Renal osteodystrophy; some therapeutic consideration relative to long-term dialysis and transplantation. Arch Intern Med (1969) 1.24
Bone disease in burn patients. J Bone Miner Res (1993) 1.23
Divalent ion metabolism and osteodystrophy in chronic renal failure. Yale J Biol Med (1967) 1.23
Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med (1976) 1.23
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol (2008) 1.22
Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus and magnesium. Medicine (Baltimore) (1973) 1.21
Abnormalities of the musculoskeletal system in hemodialysis patients. Semin Arthritis Rheum (1975) 1.21
Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A (2000) 1.20
Microradiographic studies of bone in renal osteodystrophy. Arch Intern Med (1969) 1.19
Effects of 1 alpha,25-, 24R,25-, and 1 alpha,24R,25-hydroxylated metabolites of vitamin D3 on calcium and phosphate absorption by duodenum from intact and nephrectomized rats. Arch Biochem Biophys (1977) 1.19
The acute effects of static stretching on peak torque, mean power output, electromyography, and mechanomyography. Eur J Appl Physiol (2004) 1.19
Effect of parathyroid hormone on erythropoiesis. J Clin Invest (1981) 1.18
Effect of chronic bile duct obstruction on renal handling of salt and water. J Clin Invest (1972) 1.18
Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr (1980) 1.18
Antidiuretic principle in malignant tumor extracts from patients with inappropriate ADH syndrome. J Clin Endocrinol Metab (1968) 1.17
The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med (1980) 1.16
Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure. J Clin Endocrinol Metab (1986) 1.16
Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int (1982) 1.15
Inorganic phosphate treatment of hypercalcemia. Arch Intern Med (1968) 1.15
The thyroid in end-stage renal disease. Medicine (Baltimore) (1988) 1.15
Effect of adrenergic blocking agents on the vasopressin inhibiting action of norepinephrine. Proc Soc Exp Biol Med (1970) 1.12
The problem and unanswered questions. Renal osteodystrophy, soft tissue calcification, and distrubed divalent ion metabolism in chronic renal failure. Arch Intern Med (1969) 1.12
Interrelated effects of antidiuretic hormone and adrenergic drugs on water metabolism. Am J Physiol (1971) 1.11
Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin. Ann Intern Med (1977) 1.11
Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int (1981) 1.11
Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms. J Clin Invest (1970) 1.10
Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest (1985) 1.10
Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone. J Clin Invest (1974) 1.10
Effects and interactions of 24R,25(OH)2D3 and 1,25(OH)2D3 on bone. Am J Physiol (1980) 1.10
Antidiuretic hormone in cerebrospinal fluid during endogenous and exogenous changes in its blood level. Endocrinology (1968) 1.08